Aldeyra Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ALDX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.47 M-8.56 M-7.02 M-5.3 M-5.11 M -25.99 M Cash from investing activities 7.29 M-554.13 K25 M16 M0 40.45 M Cash from financing activities 1 M0120.75 K071.14 K 191.89 K Free cash flow -12.47 M-8.56 M-7.02 M-5.3 M-5.11 M -25.99 M

News

Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL (NASDAQ:ALDX)

Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

Top Healthcare Stocks for This Year According to BTIG

Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know

Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?